FDA’s Efforts to Support Value-Based Healthcare

Posted by The Evidence Blog on June 27, 2018

Innovative medical treatments are being developed at an astonishing pace. However, rising medical costs are a roadblock to patient access to many of these innovations. Last month, Secretary of Health and Human Services Alex Azar rolled out a blueprint to address this challenge. The blueprint highlights the importance of linking payments for medical treatments to their value and removing regulatory obstacles to value-based purchasing.

Read More

Topics: FDA, value based healthcare

Sign up to receive updates from our blog

Our latest articles

New Call-to-action